Oral paper presented by Alex Carballo-Diéguez at IAS 2013.   Click for slides. Abstract: Background: Adherence to product use is the cornerstone of microbicide studies. This is the first study to assess how frequently mainly ethnic minority MSM, ages 18-30, with a history of unprotected receptive anal intercourse (RAI) in the prior year, would self-administer gel using Read More >>

Via AIDSMap, by Gus Cairns. Two consecutive sessions at the sixth International AIDS Society conference in Rome yesterday were devoted, now we have convincing scientific data on the benefits of treatment as prevention and PrEP, to putting these new prevention methods into practice. “We have moved from ‘What if?’ to ‘What now?’” was the comment of Mitchell Read More >>

OFFICIAL PRESS RELEASE – DAY 4 16.30 (CET), WEDNESDAY JULY 20 Late Breaker extracts – newsmakers First global study of real-world circumcision rollout conducted over three-year period in South Africa amongst 110,000 adults shows a marked reduction (>60%) of HIV acquisition among circumcised adult men . Elvitegravir once-daily is non inferior to raltegravir twice-daily in treatment experienced Read More >>

From the Guardian, by Sarah Boseley. There appears to be real excitement at the International Aids Society conference in Rome (sadly I’m not there in person, but that is the feedback). There is still no vaccine on the horizon – once the biggest hope – but the news from recent studies that taking antiretroviral drugs protects people Read More >>

Today is Day 3 of the exciting conference happening in Rome, and IRMA has a lot of interesting information to report. Here is the press release for Day 3, and below it are links to important and fascinating presentations from and articles about the conference. Via IAS. OFFICIAL PRESS RELEASE – DAY 3                                                          EMBARGOED UNTIL Read More >>

OFFICIAL PRESS RELEASE – DAY 2 16.30 (CET), MONDAY JULY 18 Antiretroviral Treatment is HIV Prevention: The proof is here Leading researchers and international experts to discuss the policy and prevention implications of three groundbreaking trial results: the HPTN O52 study, the Centers for Disease Control and Prevention TDF2 study and the University of Washington Partners PrEP Read More >>

The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention began yesterday in Rome, Italy. Here is the press release from yesterday’s events: OFFICIAL PRESS RELEASE – DAY 1 17.00 (CET), SUNDAY JULY 17 AIDS is at a scientific watershed, says IAS 2011 International Chair Elly Katabira at the opening of the world’s largest open scientific conference Read More >>

Via PlusNews. The sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention started optimistically as the hype surrounding the use of antiretroviral treatment to prevent HIV infection gained momentum. But the focus of much discussion in Rome from 17-20 July will undoubtedly be on how to transform the recent promising research findings into workable policy. The Read More >>

This the beginning of IRMA’s coverage of the IAS conference in Rome which opened yesterday, and which is being attended by several IRMA advocates. Via Associated Press, by Alessandra Rizzo. The head of the United Nations AIDS program called Sunday for an increase in access to drugs that help treat or prevent the spread of the disease, Read More >>

The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) kicks off on Sunday, 17 July and promises to offer a wealth of important scientific news, including the first full presentation on HPTN 052 and new data on a wide-range of topics including elite controllers, gene therapy, effectiveness of existing treatment regimens, co-infections, microbicides, PrEP, Read More >>